Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.57 |
| ▸ | NPC1 | O15118 | 6/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.57 |
| ▸ | GAA | P10253 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SYNJ2 | O15056 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12886328 | 0.88 | ALDH1A1 (0.50) | NPC1GAAALDH1A1LMNAHTT | |
| SCHEMBL23488450 | 0.88 | KMT2A (0.47) | RAB9ANPC1SMN1; SMN2GAAPTPN1 | |
| SCHEMBL23488597 | 0.87 | SMN1; SMN2 (0.55) | RAB9ANPC1SMN1; SMN2GAAPTPN1 | |
| SCHEMBL20691410 | 0.87 | ALDH1A1 (0.51) | NPC1GAAALDH1A1LMNAHTT | |
| SCHEMBL23488280 | 0.83 | MAPT (0.48) | SMN1; SMN2ALDH1A1KMT2AMEN1KDM4E | |
| SCHEMBL23488147 | 0.81 | SMN1; SMN2 (0.47) | RAB9ANPC1SMN1; SMN2GAAPTPN1 | |
| SCHEMBL19518850 | 0.80 | ALDH1A1 (0.49) | NPC1GAAALDH1A1LMNAHTT | |
| SCHEMBL23488290 | 0.78 | TDP1 (0.42) | SMN1; SMN2ALDH1A1LMNAKMT2AMEN1 | |
| SCHEMBL16155403 | 0.78 | ALDH1A1 (0.46) | NPC1GAAALDH1A1LMNAHTT | |
| SCHEMBL23488604 | 0.78 | CHRNB2 (0.53) | RAB9ANPC1SMN1; SMN2GAAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | SANOFI (FR) | 2021-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210170033-A1 | NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN | GPR119, SLC2A8, SLC2A4 | RAB9A 1043/4885NPC1 1840/4885SMN1; SMN2 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.